Improving TB diagnosis: Difference between knowing the path and walking the path

Expert Review of Molecular Diagnostics

Volumn 11, Issue 3, 2011, Pages 241-244

  Pai, Madhukar ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

diagnosis; DOTS; new diagnostics; tuberculosis; Xpert MTB RIF

Indexed keywords

RIFAMPICIN;

AUTOMATION; BIOSAFETY; DISEASE TRANSMISSION; EDITORIAL; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; MICROSCOPY; NUCLEIC ACID AMPLIFICATION; OUTCOME ASSESSMENT; SHORT COURSE THERAPY; TUBERCULOSIS; TUBERCULOSIS CONTROL; WORLD HEALTH ORGANIZATION;

DELIVERY OF HEALTH CARE; DISEASE MANAGEMENT; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; NUCLEIC ACID AMPLIFICATION TECHNIQUES; TUBERCULOSIS, PULMONARY;

EID: 79953834001     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.11.6     Document Type: Editorial

References (20)

1. WHO. Global Tuberculosis Control 2010. WHO, Geneva, Switzerland, 1-218 (2010).
2. Lonnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc. Sci. Med. 68(12), 2240-2246 (2009).
3. Oxlade O, Schwartzman K, Behr M et al. Global tuberculosis trends: a reflection of changes in tuberculosis control or in population health? Int. J. Tuberc. Lung Dis. 13(10), 1-9 (2009).
4. Dye C, Williams BG. The population dynamics and control of tuberculosis. Science 328(5980), 856-861 (2010).
5. Wallis RS, Pai M, Menzies D et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 375(9729), 1920-1937 (2010).
6. WHO. Global plan to stop tuberculosis 2011-2015. WHO, Geneva, Switzerland, 1-100 (2010).
7. WHO. Fact sheet. Expanding and accelerating access to diagnostics for patients at risk of multidrug-resistant tuberculosis. WHO, Geneva, Switzerland, 1-2 (2010).
8. WHO. Roadmap for rolling out Xpert MTB/RIF for rapid diagnosis of TB and MDR-TB. WHO, Geneva, Switzerland (2010).
9. Boehme CC, Nabeta P, Hillemann D et al. Rapid molecular detection of tuberculosis and rifampin resistance. N. Engl. J. Med. 363(11), 1005-1015 (2010).
10. Abu-Raddad LJ, Sabatelli L, Achterberg JT et al. Epidemiological benefits of moreeffective tuberculosis vaccines, drugs, and diagnostics. Proc. Natl Acad. Sci. USA 106(33), 13980-13985 (2009).
11. Small PM, Pai M. Tuberculosis diagnosis - time for a game change. N. Engl. J. Med. 363(11), 1070-1071 (2010).
12. Sreeramareddy CT, Panduru KV, Menten J, Van den Ende J. Time delays in diagnosis of pulmonary tuberculosis: a systematic review of literature. BMC Infect. Dis. 9, 91 (2009).
13. Storla DG, Yimer S, Bjune GA. A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health 8, 15 (2008).
14. Specter M. A Deadly Misdiagnosis. Is it possible to save the millions of people who die from TB? New Yorker, 15 November 2010 (2010).
15. Morris K. WHO recommends against inaccurate tuberculosis tests. Lancet 377, 113-114 (2011).
16. Steingart KR, Henry M, Laal S et al. A systematic review of commercial serological antibody detection tests for the diagnosis of extra-pulmonary tuberculosis. Thorax 62, 911-918 (2007).
17. Steingart KR, Henry M, Laal S et al. Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: a systematic review. PLoS Med. 4(6), e202 (2007).
18. Hopewell PC, Pai M, Maher D, Uplekar M, Raviglione MC. International standards for tuberculosis care. Lancet Infect. Dis. 6(11), 710-725 (2006).
19. Uplekar MW, Shepard DS. Treatment of tuberculosis by private general practitioners in India. Tubercle 72(4), 284-290 (1991).
20. Udwadia ZF, Pinto LM, Uplekar MW. Tuberculosis management by private practitioners in Mumbai, India: has anything changed in two decades? PLoS ONE 5(8), e12023 (2010).